Evaluation of the safety and tolerability of exogenous ketosis induced by orally administered free beta-hydroxybutyrate in healthy adult subjects

Beta-hydroxybutyrate (D-BHB) is a metabolite with intrinsic signalling activity that has gained attention as a potentially clinically useful supplement. There are available supplements for inducing ketosis: ketone salts, ketone esters and medium-chain triglycerides. Even when all of them raise D-BHB...

Full description

Saved in:
Bibliographic Details
Published inBMJ nutrition, prevention & health Vol. 6; no. 2; pp. 122 - 126
Main Authors Pimentel-Suarez, Lisa Isabel, Soto-Mota, Adrian
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd 01.12.2023
BMJ Publishing Group LTD
BMJ Publishing Group
Subjects
Online AccessGet full text
ISSN2516-5542
2516-5542
DOI10.1136/bmjnph-2023-000672

Cover

Loading…
Abstract Beta-hydroxybutyrate (D-BHB) is a metabolite with intrinsic signalling activity that has gained attention as a potentially clinically useful supplement. There are available supplements for inducing ketosis: ketone salts, ketone esters and medium-chain triglycerides. Even when all of them raise D-BHB in the blood and all are safe and well tolerated, they significantly differ in their safety profile, their palatability and their price. A fourth and potentially interesting option is to use biologically identical D-BHB, which it is already commercially available in the USA (American Ketone) and Greater China (MedPHA). However, its safety and tolerability had not yet been documented in the scientific literature. We evaluated the safety and tolerability of orally administered free D-BHB in a gender and age-balanced sample of 24 asymptomatic and overtly healthy adults. No participant showed acid-base abnormalities or electrolyte abnormalities. Secondary symptoms were reported after only 6.2% of all drink takes and none of the reports described the symptom as ‘severe’. The most frequently reported secondary effects (19/720 or 2.6%) were gastrointestinal discomfort, headache (7/720 or 1%) and loss of appetite (7/720 or 1%). No correlation between weight-adjusted dose and frequency of secondary symptoms was observed. Free D-BHB was a safe and well-tolerated intervention for inducing sustained exogenous ketosis. Being bioidentical, salt-free and lacking intermediate metabolites, this form of supplementation could have a larger safety spectrum than salt or alcohol-based exogenous ketones. More research is warranted to assess its clinical efficacy in those clinical scenarios in which achieving ketosis rapidly could be beneficial.
AbstractList Beta-hydroxybutyrate (D-BHB) is a metabolite with intrinsic signalling activity that has gained attention as a potentially clinically useful supplement. There are available supplements for inducing ketosis: ketone salts, ketone esters and medium-chain triglycerides. Even when all of them raise D-BHB in the blood and all are safe and well tolerated, they significantly differ in their safety profile, their palatability and their price. A fourth and potentially interesting option is to use biologically identical D-BHB, which it is already commercially available in the USA (American Ketone) and Greater China (MedPHA). However, its safety and tolerability had not yet been documented in the scientific literature. We evaluated the safety and tolerability of orally administered free D-BHB in a gender and age-balanced sample of 24 asymptomatic and overtly healthy adults. No participant showed acid-base abnormalities or electrolyte abnormalities. Secondary symptoms were reported after only 6.2% of all drink takes and none of the reports described the symptom as ‘severe’. The most frequently reported secondary effects (19/720 or 2.6%) were gastrointestinal discomfort, headache (7/720 or 1%) and loss of appetite (7/720 or 1%). No correlation between weight-adjusted dose and frequency of secondary symptoms was observed. Free D-BHB was a safe and well-tolerated intervention for inducing sustained exogenous ketosis. Being bioidentical, salt-free and lacking intermediate metabolites, this form of supplementation could have a larger safety spectrum than salt or alcohol-based exogenous ketones. More research is warranted to assess its clinical efficacy in those clinical scenarios in which achieving ketosis rapidly could be beneficial.
Beta-hydroxybutyrate (D-BHB) is a metabolite with intrinsic signalling activity that has gained attention as a potentially clinically useful supplement. There are available supplements for inducing ketosis: ketone salts, ketone esters and medium-chain triglycerides. Even when all of them raise D-BHB in the blood and all are safe and well tolerated, they significantly differ in their safety profile, their palatability and their price. A fourth and potentially interesting option is to use biologically identical D-BHB, which it is already commercially available in the USA (American Ketone) and Greater China (MedPHA). However, its safety and tolerability had not yet been documented in the scientific literature. We evaluated the safety and tolerability of orally administered free D-BHB in a gender and age-balanced sample of 24 asymptomatic and overtly healthy adults. No participant showed acid-base abnormalities or electrolyte abnormalities. Secondary symptoms were reported after only 6.2% of all drink takes and none of the reports described the symptom as 'severe'. The most frequently reported secondary effects (19/720 or 2.6%) were gastrointestinal discomfort, headache (7/720 or 1%) and loss of appetite (7/720 or 1%). No correlation between weight-adjusted dose and frequency of secondary symptoms was observed. Free D-BHB was a safe and well-tolerated intervention for inducing sustained exogenous ketosis. Being bioidentical, salt-free and lacking intermediate metabolites, this form of supplementation could have a larger safety spectrum than salt or alcohol-based exogenous ketones. More research is warranted to assess its clinical efficacy in those clinical scenarios in which achieving ketosis rapidly could be beneficial.Beta-hydroxybutyrate (D-BHB) is a metabolite with intrinsic signalling activity that has gained attention as a potentially clinically useful supplement. There are available supplements for inducing ketosis: ketone salts, ketone esters and medium-chain triglycerides. Even when all of them raise D-BHB in the blood and all are safe and well tolerated, they significantly differ in their safety profile, their palatability and their price. A fourth and potentially interesting option is to use biologically identical D-BHB, which it is already commercially available in the USA (American Ketone) and Greater China (MedPHA). However, its safety and tolerability had not yet been documented in the scientific literature. We evaluated the safety and tolerability of orally administered free D-BHB in a gender and age-balanced sample of 24 asymptomatic and overtly healthy adults. No participant showed acid-base abnormalities or electrolyte abnormalities. Secondary symptoms were reported after only 6.2% of all drink takes and none of the reports described the symptom as 'severe'. The most frequently reported secondary effects (19/720 or 2.6%) were gastrointestinal discomfort, headache (7/720 or 1%) and loss of appetite (7/720 or 1%). No correlation between weight-adjusted dose and frequency of secondary symptoms was observed. Free D-BHB was a safe and well-tolerated intervention for inducing sustained exogenous ketosis. Being bioidentical, salt-free and lacking intermediate metabolites, this form of supplementation could have a larger safety spectrum than salt or alcohol-based exogenous ketones. More research is warranted to assess its clinical efficacy in those clinical scenarios in which achieving ketosis rapidly could be beneficial.
Author Soto-Mota, Adrian
Pimentel-Suarez, Lisa Isabel
Author_xml – sequence: 1
  givenname: Lisa Isabel
  surname: Pimentel-Suarez
  fullname: Pimentel-Suarez, Lisa Isabel
  organization: School of Medicine, Tecnologico de Monterrey - Campus Ciudad de Mexico, Ciudad de Mexico, Mexico
– sequence: 2
  givenname: Adrian
  orcidid: 0000-0002-9173-7440
  surname: Soto-Mota
  fullname: Soto-Mota, Adrian
  email: adrian.sotom@incmnsz.mx
  organization: School of Medicine, Tecnologico de Monterrey - Campus Ciudad de Mexico, Ciudad de Mexico, Mexico
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38618543$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1u1DAUhSNURH_oC7BAltiwSfFv4ixRVWilSmxgbdnxTePgiQfbQZ3H6BvjaUpBXczK1rnfObav72l1NIcZquodwReEsOaT2UzzdqwppqzGGDctfVWdUEGaWghOj_7bH1fnKU2FKQohsn1THTPZECk4O6kern5rv-jswozCgPIIKOkB8g7p2aIcPERtnHdFKGW4D3cwhyWhn5BDcgm52S49WGRKPWrvi89u3OxShljkIQIgA1nX487GcL8zS95FnaEY0Qja53HvWHxGaTET9Dm9rV4P2ic4f1rPqh9frr5fXte3377eXH6-rY3AMte2sVZz3ktmAYyADlspKdN83xEDkpFBMmGLzrmxhgwNHzqGB6B44FYIdlbdrLk26Elto9vouFNBO_UohHindMyu96Ba3hphSi4WmDe6xHeMG21b0kiJRV-yPq5Z2xh-LZCy2rjUg_d6htItxTDrKGsp3x_74QU6hSXO5aWKdrglpOkoP0hJxiTBHSOFev9ELWYD9vkRf7-3AHQF-hhSijA8IwSr_RipdYzUvmlqHaNiki9MvcuPE5Kjdv6w9WK1ltq_Gx8w_AHNk92x
CitedBy_id crossref_primary_10_3389_fnut_2025_1538266
crossref_primary_10_1152_ajpcell_00485_2023
crossref_primary_10_1016_j_phanu_2025_100437
Cites_doi 10.24875/RIC.22000281
10.3389/fpsyt.2022.951376
10.1017/S0007114521003883
10.4102/jir.v4i1.47
10.3389/fnut.2019.00063
10.1161/CIRCULATIONAHA.118.036459
10.1177/0885066609356164
10.1097/MED.0000000000000564
10.1123/ijsnem.2019-0014
10.1016/j.nut.2014.06.011
10.1016/j.cellsig.2016.04.005
10.1038/s41569-020-0363-2
10.1016/j.arres.2021.100009
10.3390/nu13030854
10.1038/s41598-023-28499-y
10.1002/edm2.300
10.1146/annurev.nutr.26.061505.111258
10.3389/fphys.2017.00848
10.1093/jn/132.3.329
10.1042/BST20190240
10.3389/fnut.2021.618520
10.1016/j.yrtph.2019.104506
10.1016/bs.irn.2020.02.003
10.1017/jns.2021.67
10.1016/j.cmet.2019.09.012
10.15227/orgsyn.071.0039
10.1016/J.ARRES.2021.100009
ContentType Journal Article
Copyright Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
– notice: 2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 9YT
ACMMV
AAYXX
CITATION
NPM
3V.
7RV
7X7
7XB
8C1
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
KB0
M0S
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOA
DOI 10.1136/bmjnph-2023-000672
DatabaseName BMJ Open Access Journals
BMJ Journals:Open Access
CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Nursing & Allied Health Database (NC LIVE)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Public Health Database (NC LIVE)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
ProQuest Public Health
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
ProQuest Health & Medical Research Collection
MEDLINE - Academic
DatabaseTitleList ProQuest Public Health
CrossRef
MEDLINE - Academic


ProQuest Public Health
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: ACMMV
  name: BMJ Journals:Open Access
  url: https://journals.bmj.com/
  sourceTypes: Publisher
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 2516-5542
EndPage 126
ExternalDocumentID oai_doaj_org_article_747b5b02305046a3be934bad7168805c
38618543
10_1136_bmjnph_2023_000672
bmjnph
Genre Journal Article
GeographicLocations Mexico
GeographicLocations_xml – name: Mexico
GroupedDBID 7RV
7X7
8C1
8FI
8FJ
9YT
AAFWJ
ABJNI
ABUWG
ACMMV
ADBBV
AFKRA
AFPKN
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BCNDV
BENPR
CCPQU
FYUFA
GROUPED_DOAJ
HMCUK
M~E
NAPCQ
OK1
PGMZT
PHGZT
RMJ
RPM
UKHRP
AAYXX
CITATION
PHGZM
PJZUB
PPXIY
PUEGO
NPM
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-b508t-d6dda44c83deeb5e90d8823a42023be831f835de9044bdb1f64f930fe20f4d553
IEDL.DBID 9YT
ISSN 2516-5542
IngestDate Wed Aug 27 01:28:57 EDT 2025
Fri Jul 11 16:57:29 EDT 2025
Fri Jul 25 20:56:27 EDT 2025
Fri Jul 25 05:22:18 EDT 2025
Thu Apr 03 06:57:55 EDT 2025
Thu Apr 24 23:09:26 EDT 2025
Wed Sep 03 16:43:28 EDT 2025
Thu Apr 24 22:49:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords nutritional treatment
Language English
License This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b508t-d6dda44c83deeb5e90d8823a42023be831f835de9044bdb1f64f930fe20f4d553
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-9173-7440
OpenAccessLink https://nutrition.bmj.com/content/6/2/122.full
PMID 38618543
PQID 2833810931
PQPubID 5161128
PageCount 5
ParticipantIDs doaj_primary_oai_doaj_org_article_747b5b02305046a3be934bad7168805c
proquest_miscellaneous_3039237245
proquest_journals_2907116924
proquest_journals_2833810931
pubmed_primary_38618543
crossref_primary_10_1136_bmjnph_2023_000672
crossref_citationtrail_10_1136_bmjnph_2023_000672
bmj_journals_10_1136_bmjnph_2023_000672
PublicationCentury 2000
PublicationDate 2023-12-01
PublicationDateYYYYMMDD 2023-12-01
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-12-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMJ nutrition, prevention & health
PublicationTitleAbbrev BMJNPH
PublicationTitleAlternate BMJ Nutr Prev Health
PublicationYear 2023
Publisher BMJ Publishing Group Ltd
BMJ Publishing Group LTD
BMJ Publishing Group
Publisher_xml – name: BMJ Publishing Group Ltd
– name: BMJ Publishing Group LTD
– name: BMJ Publishing Group
References Nicholas, Soto-Mota, Lambert (R2) 2021; 10
Cahill, George (R6) 2006; 26
Soto-Mota, Vansant, Evans (R18) 2019; 109
Feinman, Pogozelski, Astrup (R7) 2015; 31
Cid-Juárez, Téllez-Navarrete, Bautista-Bernal (R25) 2023; 75
Buga, Kackley, Crabtree (R16) 2021; 8
Stubbs, Cox, Kirk (R20) 2019; 29
Seebach, Beck, Breitschuh (R23) 1993; 71
Rojas-Morales, Tapia, Pedraza-Chaverri (R14) 2016; 28
Norwitz, Hu, Clarke (R4) 2019; 6
Stubbs, Cox, Evans (R8) 2017; 8
Stefan, Sharp, Gheith (R17) 2021; 13
Walkey, Farber, O’Donnell (R24) 2010; 25
Gross, Putananickal, Orsini (R10) 2023; 13
Norwitz, Jaramillo, Clarke (R1) 2020; 155
St-Onge, Jones (R19) 2002; 132
Soto-Mota, Norwitz, Clarke (R13) 2020; 48
Holland, Qazi, Beasley (R15) 2019; 4
Norwitz, Sethi, Palmer (R5) 2020; 27
Myette-Côté, Soto-Mota, Cunnane (R11) 2022; 128
Nielsen, Møller, Gormsen (R12) 2019; 139
Rojas-Morales, Pedraza-Chaverri, Tapia (R22) 2021; 2
Soto-Mota, Norwitz, Evans (R3) 2022; 5
Torres, Kruger, Broderick (R21) 2019; 30
Danan, Westman, Saslow (R9) 2022; 13
Borlaug (R26) 2020; 17
Cid-Juárez (2025090109260620000_6.2.122.25) 2023; 75
2025090109260620000_6.2.122.19
Stubbs (2025090109260620000_6.2.122.20) 2019; 29
Soto-Mota (2025090109260620000_6.2.122.3) 2022; 5
2025090109260620000_6.2.122.18
Norwitz (2025090109260620000_6.2.122.1) 2020; 155
Stubbs (2025090109260620000_6.2.122.8) 2017; 8
Buga (2025090109260620000_6.2.122.16) 2021; 8
2025090109260620000_6.2.122.22
2025090109260620000_6.2.122.24
2025090109260620000_6.2.122.21
Seebach (2025090109260620000_6.2.122.23) 1993; 71
Gross (2025090109260620000_6.2.122.10) 2023; 13
2025090109260620000_6.2.122.26
Stefan (2025090109260620000_6.2.122.17) 2021; 13
Nicholas (2025090109260620000_6.2.122.2) 2021; 10
Danan (2025090109260620000_6.2.122.9) 2022; 13
Myette-Côté (2025090109260620000_6.2.122.11) 2022; 128
2025090109260620000_6.2.122.12
Norwitz (2025090109260620000_6.2.122.4) 2019; 6
2025090109260620000_6.2.122.14
2025090109260620000_6.2.122.13
Holland (2025090109260620000_6.2.122.15) 2019; 4
2025090109260620000_6.2.122.7
2025090109260620000_6.2.122.6
2025090109260620000_6.2.122.5
References_xml – volume: 75
  start-page: 29
  year: 2023
  ident: R25
  article-title: Arterial blood gases in normal subjects at 2240 meters above sea level: impact of age, gender, and body mass index
  publication-title: Rev Invest Clin
  doi: 10.24875/RIC.22000281
– volume: 13
  year: 2022
  ident: R9
  article-title: The ketogenic diet for refractory mental illness: a retrospective analysis of 31 Inpatients
  publication-title: Front Psychiatry
  doi: 10.3389/fpsyt.2022.951376
– volume: 128
  start-page: 407
  year: 2022
  ident: R11
  article-title: Ketones - potential to achieve brain energy rescue and sustain cognitive health during aging
  publication-title: Br J Nutr
  doi: 10.1017/S0007114521003883
– volume: 4
  start-page: 47
  year: 2019
  ident: R15
  article-title: Blood and cardiovascular health parameters after supplementing with ketone salts for six weeks
  publication-title: Journal of Insulin Resistance
  doi: 10.4102/jir.v4i1.47
– volume: 6
  year: 2019
  ident: R4
  article-title: The mechanisms by which the ketone body D-Β-Hydroxybutyrate may improve the multiple cellular pathologies of Parkinson’s disease
  publication-title: Front Nutr
  doi: 10.3389/fnut.2019.00063
– volume: 139
  start-page: 2129
  year: 2019
  ident: R12
  article-title: Cardiovascular effects of treatment with the ketone body 3-Hydroxybutyrate in chronic heart failure patients
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.118.036459
– volume: 25
  start-page: 104
  year: 2010
  ident: R24
  article-title: The accuracy of the central venous blood gas for acid-base monitoring
  publication-title: J Intensive Care Med
  doi: 10.1177/0885066609356164
– volume: 27
  start-page: 269
  year: 2020
  ident: R5
  article-title: Ketogenic diet as a metabolic treatment for mental illness
  publication-title: Curr Opin Endocrinol Diabetes Obes
  doi: 10.1097/MED.0000000000000564
– volume: 29
  start-page: 596
  year: 2019
  ident: R20
  article-title: Gastrointestinal effects of exogenous ketone drinks are infrequent, mild and vary according to ketone compound and dose
  publication-title: Int J Sport Nutr Exerc Metab
  doi: 10.1123/ijsnem.2019-0014
– volume: 31
  start-page: 1
  year: 2015
  ident: R7
  article-title: Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base
  publication-title: Nutrition
  doi: 10.1016/j.nut.2014.06.011
– volume: 28
  start-page: 917
  year: 2016
  ident: R14
  article-title: Β-Hydroxybutyrate: a signaling metabolite in starvation response?
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2016.04.005
– volume: 17
  start-page: 559
  year: 2020
  ident: R26
  article-title: Evaluation and management of heart failure with preserved ejection fraction
  publication-title: Nat Rev Cardiol
  doi: 10.1038/s41569-020-0363-2
– volume: 2
  start-page: 100009
  year: 2021
  ident: R22
  article-title: Ketone bodies for kidney injury and disease
  publication-title: Advances in Redox Research
  doi: 10.1016/j.arres.2021.100009
– volume: 13
  start-page: 854
  year: 2021
  ident: R17
  article-title: The effect of exogenous beta-hydroxybutyrate salt supplementation on metrics of safety and health in adolescents
  publication-title: Nutrients
  doi: 10.3390/nu13030854
– volume: 13
  year: 2023
  ident: R10
  article-title: Defining metabolic migraine with a distinct subgroup of patients with suboptimal inflammatory and metabolic markers
  publication-title: Sci Rep
  doi: 10.1038/s41598-023-28499-y
– volume: 5
  year: 2022
  ident: R3
  article-title: Exogenous D-Β-Hydroxybutyrate lowers blood glucose in part by decreasing the availability of L-alanine for gluconeogenesis
  publication-title: Endocrinol Diabetes Metab
  doi: 10.1002/edm2.300
– volume: 26
  start-page: 1
  year: 2006
  ident: R6
  article-title: Fuel metabolism in starvation
  publication-title: Annu Rev Nutr
  doi: 10.1146/annurev.nutr.26.061505.111258
– volume: 8
  year: 2017
  ident: R8
  article-title: On the metabolism of exogenous ketones in humans
  publication-title: Front Physiol
  doi: 10.3389/fphys.2017.00848
– volume: 132
  start-page: 329
  year: 2002
  ident: R19
  article-title: Physiological effects of medium-chain triglycerides: potential of obesity
  publication-title: The Journal of Nutrition
  doi: 10.1093/jn/132.3.329
– volume: 48
  start-page: 51
  year: 2020
  ident: R13
  article-title: Why a D-Β-Hydroxybutyrate monoester?
  publication-title: Biochem Soc Trans
  doi: 10.1042/BST20190240
– volume: 8
  year: 2021
  ident: R16
  article-title: The effects of a 6-week controlled, hypocaloric ketogenic diet, with and without exogenous ketone salts, on body composition responses
  publication-title: Front Nutr
  doi: 10.3389/fnut.2021.618520
– volume: 109
  start-page: 104506
  year: 2019
  ident: R18
  article-title: Safety and tolerability of sustained exogenous ketosis using ketone Monoester drinks for 28 days in healthy adults
  publication-title: Regul Toxicol Pharmacol
  doi: 10.1016/j.yrtph.2019.104506
– volume: 155
  start-page: 141
  year: 2020
  ident: R1
  article-title: Ketotherapeutics for neurodegenerative diseases
  publication-title: Int Rev Neurobiol
  doi: 10.1016/bs.irn.2020.02.003
– volume: 10
  year: 2021
  ident: R2
  article-title: Restricting carbohydrates and calories in the treatment of type 2 diabetes: a systematic review of the effectiveness of 'low-carbohydrate' interventions with differing energy levels
  publication-title: J Nutr Sci
  doi: 10.1017/jns.2021.67
– volume: 30
  start-page: 1007
  year: 2019
  ident: R21
  article-title: Ketosis ameliorates renal cyst growth in polycystic kidney disease
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2019.09.012
– volume: 71
  start-page: 39
  year: 1993
  ident: R23
  article-title: Direct degradation of the biopolymer Poly[(R)-3-Hydroxybutyric acid] to (R)-3-Hydroxybutanoic acid and its methyl ester
  publication-title: Org Synth
  doi: 10.15227/orgsyn.071.0039
– ident: 2025090109260620000_6.2.122.12
  doi: 10.1161/CIRCULATIONAHA.118.036459
– volume: 13
  start-page: 854
  year: 2021
  ident: 2025090109260620000_6.2.122.17
  article-title: The effect of exogenous beta-hydroxybutyrate salt supplementation on metrics of safety and health in adolescents
  publication-title: Nutrients
  doi: 10.3390/nu13030854
– ident: 2025090109260620000_6.2.122.7
  doi: 10.1016/j.nut.2014.06.011
– ident: 2025090109260620000_6.2.122.6
  doi: 10.1146/annurev.nutr.26.061505.111258
– volume: 155
  start-page: 141
  year: 2020
  ident: 2025090109260620000_6.2.122.1
  article-title: Ketotherapeutics for neurodegenerative diseases
  publication-title: Int Rev Neurobiol
  doi: 10.1016/bs.irn.2020.02.003
– ident: 2025090109260620000_6.2.122.14
  doi: 10.1016/j.cellsig.2016.04.005
– volume: 5
  year: 2022
  ident: 2025090109260620000_6.2.122.3
  article-title: Exogenous D-Β-Hydroxybutyrate lowers blood glucose in part by decreasing the availability of L-alanine for gluconeogenesis
  publication-title: Endocrinol Diabetes Metab
  doi: 10.1002/edm2.300
– volume: 29
  start-page: 596
  year: 2019
  ident: 2025090109260620000_6.2.122.20
  article-title: Gastrointestinal effects of exogenous ketone drinks are infrequent, mild and vary according to ketone compound and dose
  publication-title: Int J Sport Nutr Exerc Metab
  doi: 10.1123/ijsnem.2019-0014
– ident: 2025090109260620000_6.2.122.26
  doi: 10.1038/s41569-020-0363-2
– volume: 71
  start-page: 39
  year: 1993
  ident: 2025090109260620000_6.2.122.23
  article-title: Direct degradation of the biopolymer Poly[(R)-3-Hydroxybutyric acid] to (R)-3-Hydroxybutanoic acid and its methyl ester
  publication-title: Org Synth
  doi: 10.15227/orgsyn.071.0039
– ident: 2025090109260620000_6.2.122.13
  doi: 10.1042/BST20190240
– ident: 2025090109260620000_6.2.122.24
  doi: 10.1177/0885066609356164
– volume: 8
  year: 2017
  ident: 2025090109260620000_6.2.122.8
  article-title: On the metabolism of exogenous ketones in humans
  publication-title: Front Physiol
  doi: 10.3389/fphys.2017.00848
– volume: 128
  start-page: 407
  year: 2022
  ident: 2025090109260620000_6.2.122.11
  article-title: Ketones - potential to achieve brain energy rescue and sustain cognitive health during aging
  publication-title: Br J Nutr
  doi: 10.1017/S0007114521003883
– volume: 13
  year: 2022
  ident: 2025090109260620000_6.2.122.9
  article-title: The ketogenic diet for refractory mental illness: a retrospective analysis of 31 Inpatients
  publication-title: Front Psychiatry
  doi: 10.3389/fpsyt.2022.951376
– ident: 2025090109260620000_6.2.122.18
  doi: 10.1016/j.yrtph.2019.104506
– volume: 13
  year: 2023
  ident: 2025090109260620000_6.2.122.10
  article-title: Defining metabolic migraine with a distinct subgroup of patients with suboptimal inflammatory and metabolic markers
  publication-title: Sci Rep
  doi: 10.1038/s41598-023-28499-y
– ident: 2025090109260620000_6.2.122.5
  doi: 10.1097/MED.0000000000000564
– ident: 2025090109260620000_6.2.122.21
  doi: 10.1016/j.cmet.2019.09.012
– volume: 75
  start-page: 29
  year: 2023
  ident: 2025090109260620000_6.2.122.25
  article-title: Arterial blood gases in normal subjects at 2240 meters above sea level: impact of age, gender, and body mass index
  publication-title: Rev Invest Clin
– volume: 8
  year: 2021
  ident: 2025090109260620000_6.2.122.16
  article-title: The effects of a 6-week controlled, hypocaloric ketogenic diet, with and without exogenous ketone salts, on body composition responses
  publication-title: Front Nutr
  doi: 10.3389/fnut.2021.618520
– ident: 2025090109260620000_6.2.122.22
  doi: 10.1016/J.ARRES.2021.100009
– ident: 2025090109260620000_6.2.122.19
  doi: 10.1093/jn/132.3.329
– volume: 6
  year: 2019
  ident: 2025090109260620000_6.2.122.4
  article-title: The mechanisms by which the ketone body D-Β-Hydroxybutyrate may improve the multiple cellular pathologies of Parkinson’s disease
  publication-title: Front Nutr
  doi: 10.3389/fnut.2019.00063
– volume: 10
  year: 2021
  ident: 2025090109260620000_6.2.122.2
  article-title: Restricting carbohydrates and calories in the treatment of type 2 diabetes: a systematic review of the effectiveness of 'low-carbohydrate' interventions with differing energy levels
  publication-title: J Nutr Sci
  doi: 10.1017/jns.2021.67
– volume: 4
  start-page: 47
  year: 2019
  ident: 2025090109260620000_6.2.122.15
  article-title: Blood and cardiovascular health parameters after supplementing with ketone salts for six weeks
  publication-title: Journal of Insulin Resistance
SSID ssj0002511187
Score 2.2803004
Snippet Beta-hydroxybutyrate (D-BHB) is a metabolite with intrinsic signalling activity that has gained attention as a potentially clinically useful supplement. There...
SourceID doaj
proquest
pubmed
crossref
bmj
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 122
SubjectTerms Acids
Birth control
Carbon dioxide
Electrolytes
Heart
Hypothesis testing
Illnesses
Ketosis
Medical personnel
Nutrition research
nutritional treatment
Original research
Sample size
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQT1wQqBQCLXKlShxQ1E38keQIqFXFgROVeos88VgFQlJtslL3Z_CPmYmzoUi0XLjaniT2jO038fiNECeNxYpMB1KXcQoz3Zi0DJVN3Sp3Kw9NATHK97O9uNSfrszVnVRfHBMW6YHjwJ0S3AUDjJQNuXJOAT1bg_OE88n0TMOrL-15d5wpXoMZOGdlsbslo-wp_PjW3VynnC08ndbonHYTKvxjP5po--_HmtOec_5UPJnBonwfP_KZeITdvvh5thB0yz5IAnBycAHHrXSdl2Pf4jpyb2-5Gm_7SMMqv-PYD18HSU44qdNLoPq1a1uSmwl0OW2nDGtECTi69HrrOcYFNuOW-SRIUMZbkyyxaUc5bID_4gzPxeX52ZePF-mcWCEFwmNj6q33jvRSKo8IBquVJ6CtnObRASxVFgiYeSrXGjxkwepAGg2Yr4L2xqgDsdf1Hb4UUvk8VEVj-MRPewylLwwGaxR4UjdgIt7SINfzxBjqyedQto7qqPmFdVRHIrKdIupm5ifnNBntgzLvFpmbyM7xYOsPrN-lJTNrTwVkb_Vsb_W_7C0Rhzvr-N0rwmjMlFap7O_VFQG5zJKrm4jjpZrmMR_OuA7JCGqCEoS1i1ybRLyIRrd8qCotwSqtXv2PDrwWj6dJMIXkHIq9cb3BIwJWI7yZ5tAvzUkgAQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Ni9UwEA-6XryI4ld1lQiCBwnbNh9tT6Kyy-LBkwvvVpJm4qq1fbZ94Psz_I-dSfsqgr5bSTL9yEyS3yTT3zD2sjFQoek4YTNKYaYaLcpQGWHT3KbeNYWbo3w_mssr9WGjN8uG27iEVR7mxDhR-76hPfKzHL24LDPoLrzZ_hCUNYpOV5cUGjfZLaIuo5CuYlOseywEn7OYIw-vjMCVMz_8NyPNmfv-tdteC8ofLuKsneP6goV_rVCRyP__6DOuQhd32Z0FPvK3s77vsRvQ3We_zlfKbt4HjpCOjzbAtOe283zqWxhmNu49VcPPfiZm5d9g6scvI0e3HBXsucP6wbYtyi2UupTIk4cBgDuYrLjee4p6cbtpTwwTKMjn_yhJYtdOfNw52tcZH7Cri_NP7y_FkmpBOERok_DGe4uaKqUHcBqq1CP0llZR7zgoZRYQqnksV8p5lwWjAuo4QJ4G5bWWD9lJ13fwmHHp81AVjaYzQOUhlL7QEIyWzqMBOEjYK-zkehkqYx29EGnqWR01PbCe1ZGw7KCIulkYyylxRntU5vUqs535Oo62fkf6XVsS13Ys6IfP9TJ0a3S4nHbkq-lUGYvdUUnlrEdPEyc_3STs9GAdf74KURtxp1Uy-3f1as0Je7FW48im4xrbARpBjeAC0XeRK52wR7PRrS8qS4NAS8knx2_-lN2O5h3Db07ZyTTs4BmCqMk9jyPlN_PAGno
  priority: 102
  providerName: ProQuest
Title Evaluation of the safety and tolerability of exogenous ketosis induced by orally administered free beta-hydroxybutyrate in healthy adult subjects
URI https://nutrition.bmj.com/content/6/2/122.full
https://www.ncbi.nlm.nih.gov/pubmed/38618543
https://www.proquest.com/docview/2833810931
https://www.proquest.com/docview/2907116924
https://www.proquest.com/docview/3039237245
https://doaj.org/article/747b5b02305046a3be934bad7168805c
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLbY9sILAnErjMpISDygrEl8SfK4VZ0mpE0Ibag8RXZss0FIpsSV6M_gH3NOnAYhwcRLK9k5TervOP6OL98h5E0lbQGuoyOVYAozXokod4WMVJyq2Ogq02GX74U8u-Lv12I9Bop4FqbZadAf6e9fw5kGVGlq_EIu0kWSpkc4Lb1HDjAxCW7hKj5fTnMqSJeTPNudjWFyAT_S3F5HmCM8Gt7MKYwhUPjHKDSI9f-bYQ4jzelD8mCkiPQ4YPqI3LPNY_JzNcly09ZRoG20V876LVWNob6tbRcUt7dYbX-0QXyVfrO-7W96CqE3gGiohvpO1TXYjbK5mKyTus5aqq1X0fXW4M4WvfFbVJEAQxrOSqLFpva032icu-mfkKvT1eXyLBrTKUQaWJiPjDRGARo5M9ZqYYvYAL1mimPraJuzxAEdM1DOuTY6cZI7wNHZNHbcCMGekv2mbexzQplJXZFVAtf5uLEuN5mwTgqmDYCs7Yy8hUYux-7Ql0OkwWQZ4CjxhmWAY0aSHRBlNaqSY3KM-k6bd5PNbdDkuPPqE8R3uhL1tIeCtvtSjt2zhKBKC43xmIi5VNAcBeNaGYgm4QUnqhk53HnH738FzAz10QqW_L26APqWSAhwZ-T1VA29F5dkVGPBCUogEMCws5SLGXkWnG56UJZLIFOcvfjvxnxJ7g-ePuy2OST7vtvYV8CZvJ6TvWydwWe-TOZDp5mTg-Pl-fkn-D5ZXXz4OB9mI34BZeIbaA
linkProvider BMJ Publishing Group Ltd
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5V7QEuCMQrUGCRQBzQqrH3kfiAEIVUKS0RQq3Um9n1ztJCsEPsCPIz-CP8Rmb8QkiQW2_Rrid-zOzMN_uYj7EnmYEETccJGxGFmcq0GIfECDuM7dC7bOSaXb4zMz1Vb8_02Rb71Z2FoW2VnU-sHbUvMpoj34sxi4sig-nCy8U3QaxRtLraUWg0ZnEE6--YspUvDt-gfp_G8cHk5PVUtKwCwiEYqYQ33lt8qLH0AE5DMvSIMqVVRCTuYCyjgKjEY7tSzrsoGBXwdQLEw6C8JpYIdPk7SmIqs8129iez9x_6WR0C7FHNyoe_jMBYHXcndaTZc18_54tzQTcSdZyIMaJh418xsaYO-D_erePewXV2rQWs_FVjYTfYFuQ32c9JXyScF4EjiOSlDVCtuc09r4o5LJv632vqhh9FUwqWf4GqKC9KfpF7NCnPHfYv7XyOcm0RX6IO5WEJwB1UVpyvPe2zcatqTTUtUJA3JzdJYjWveLlyNJNU3mKnl6KG22w7L3K4y7j0cUhGmaZVR-UhjP1IQzBaOo8m52DAnuFHTtvBWaZ13iNN2qgjpRumjToGLOoUkWZtjXSi6phvlHneyyyaCiEbr94n_fZXUnXvuqFYfkpbZ5Fiiue0o-xQD5Wx-DkSqZz1mNuiu9XZgO121vHnrRAnUrW2REb_7u7Hz4A97rvRl9ACkc0BjSBFOIN4fxQrPWB3GqPrH1SODUI7Je9t_vNH7Mr05N1xenw4O7rPrtamXm_-2WXb1XIFDxDCVe5hO244-3jZQ_U3aexZPQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VRUJcEIhXoMAigTigVWLvw_EBIaCNWooqDlTKzex6Z9tCsEPsCPIz-Dv8Omb8QkiQW2_Rrid-zOub3dkZxp7mBlIUHSdsRC3MVK7FNKRG2ElsJ97liWuzfE_M4al6N9fzHfarPwtDaZW9TWwMtS9zWiMfxxjFRZHBcGEcurSID_uzV8tvgjpI0U5r306jFZFj2HzH8K16ebSPvH4Wx7ODj28PRddhQDgEJrXwxnuLDziVHsBpSCceEae0ipqKO5jKKCBC8TiulPMuCkYFfLUA8SQor6ljBJr_K4nUEelYMk-G9R2C7lHTnw9_GYFeO-7P7Egzdl8_F8tzQbcRjceI0bfh4F_esWki8H_k23jA2Q12vYOu_HUrazfZDhS32M-DoVw4LwNHOMkrG6DecFt4XpcLWLWVwDc0DT_Ktigs_wJ1WV1U_KLwKFyeO5xf2cUC6bpyvtRElIcVAHdQW3G-8ZRx49b1hqpbICFvz3ASxXpR82rtaE2pus1OL4UJd9huURZwj3Hp45Amuab9R-UhTH2iIRgtnUfhczBiz_EjZ52aVlkTAUmTtezI6IZZy44Ri3pGZHlXLZ2adiy20rwYaJZtrZCtV78h_g5XUp3vZqBcnWWd2cgw2HPaUZyoJ8pY_BypVM56jHLR8Op8xPZ66fjzVogYqW5bKqN_Tw-aNGJPhmm0KrRVZAtAIcgQ2CDyT2KlR-xuK3TDg8qpQZCn5P3tf_6YXUUFzd4fnRw_YNcaSW-ygPbYbr1aw0PEcrV71CgNZ58uW0t_A5_oXA0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+the+safety+and+tolerability+of+exogenous+ketosis+induced+by+orally+administered+free+beta-hydroxybutyrate+in+healthy+adult+subjects&rft.jtitle=BMJ+nutrition%2C+prevention+%26+health&rft.au=Pimentel-Suarez%2C+Lisa+Isabel&rft.au=Soto-Mota%2C+Adrian&rft.date=2023-12-01&rft.issn=2516-5542&rft.eissn=2516-5542&rft.volume=6&rft.issue=2&rft.spage=122&rft_id=info:doi/10.1136%2Fbmjnph-2023-000672&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2516-5542&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2516-5542&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2516-5542&client=summon